We are thrilled to announce the results of our last trial runned by Wageningen Livestock Research in collaboration with our distributor Phibro Animal Health concerning the impact of our product Anavrin on methane emission reduction in Dairy Cows by using the Climate Respiration Chambers (CRC) :

“In conclusion, Anavrin influenced both CH₄ production and CH₄ intensity. Specifically, Anavrin reduced CH₄ production by 13% and CH₄ intensity by 16.3%. This supports the hypothesis that Anavrin, can effectively mitigate enteric CH₄ emissions in dairy cows. These results highlight Anavrin’s potential as a valuable tool for reducing greenhouse gas emissions in dairy farming.”